Shinya Goto: Short-Course Rivaroxaban, Then Aspirin for Post-Arthroplasty VTE Prevention
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Sudeep Shivakumaret al., published in NEJM, adding:
”After only short course of rivaroxaban, aspirin alone is fine to prevent VTE after otal Hip or Knee Arthroplasty!”
Title: Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
Authors: Sudeep Shivakumar, Davide Matino, David Zukor, Susan R. Kahn, George Vincent, Raman Mundi, Pascal-Andre Vendittoli, Mohammad Refaei, Eric Bohm, Michael Tanzer, Stéphane Pelet, Glen Richardson, James Powell, Rick Ikesaka, James Douketis, Sarah Ward, Paul Kim, Stephen Mann, Susan Pleasance, Jocelyn Cormier, Pantelis Andreou, Kara Matheson, Chris Theriault, Carol West, David Anderson, Peter L. Gross

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?
-
Jul 20, 2026, 19:56Asima Ahmad: Decoding Heavy Bleeding – What Your Symptoms Could Be Telling You
-
Jul 20, 2026, 19:41Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders
-
Jul 20, 2026, 19:21Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
-
Jul 20, 2026, 19:06Sam Hirniak: Symptoms, Diagnosis, and Treatment for Women and Girls with Hemophilia
-
Jul 20, 2026, 18:29Masoabi Sefojane: Every Leadership Journey has it’s Season